To hear about similar clinical trials, please enter your email below

Trial Title: Feasibility of a Whole-Food, Plant-Based Diet for Patients With Low-Risk Chronic Lymphocytic Leukemia (CLL)

NCT ID: NCT06377501

Condition: Chronic Lymphocytic Leukemia Stage A(0)

Conditions: Official terms:
Leukemia
Leukemia, Lymphoid
Leukemia, Lymphocytic, Chronic, B-Cell

Conditions: Keywords:
whole-food plant-based diet
CLL

Study type: Interventional

Study phase: N/A

Overall status: Active, not recruiting

Study design:

Allocation: N/A

Intervention model: Single Group Assignment

Primary purpose: Treatment

Masking: None (Open Label)

Intervention:

Intervention type: Other
Intervention name: Whole-food, plant-based diet
Description: Subjects will be instructed to adopt a whole-food, plant-based diet for 8 weeks. They will attend weekly group cooking classes led by a RD and receive weekly health coaching sessions.
Arm group label: Intervention Group

Summary: This study will evaluate the feasibility of an 8-week vegan whole-food, plant-based dietary intervention in subjects with low risk CLL who are undergoing observation. Over the course of 8 weeks, participants will attend weekly group cooking classes via Zoom lead by a RD. Participants will also attend weekly individual meetings with a health coaches to assist with adherence to the dietary intervention.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patients who have a diagnosis of low-risk CLL according to the modified Rai staging criteria for a minimum of 12 months and are currently undergoing observation. - Access to a computer or tablet and Zoom. Exclusion Criteria: - Have active disease and are currently receiving pharmacologic treatment for CLL - Have previously received treatment for CLL - Are currently following a vegan or vegetarian diet - A previous or current diagnosis of disordered eating including anorexia, bulimia, binge eating disorder or avoidant/restrictive food intake disorder. - A diagnosis of Type 1 diabetes - A diagnosis of Insulin dependent type 2 diabetes - Currently pregnant or planning to become pregnant

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: UC San Diego

Address:
City: San Diego
Zip: 92093
Country: United States

Start date: March 7, 2023

Completion date: July 2024

Lead sponsor:
Agency: University of California, San Diego
Agency class: Other

Source: University of California, San Diego

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06377501

Login to your account

Did you forget your password?